Liquid Biopsies and Cancer Immunotherapy

被引：18
|
作者：
Thompson, Jonathan R. [1 ]
Menon, Smitha P. [1 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA
来源：
CANCER JOURNAL | 2018年 / 24卷 / 02期
关键词：
Immunotherapy; tumor microenvironment; immune checkpoint inhibitor; tumor mutation burden; CIRCULATING TUMOR DNA; PROGRESSION-FREE SURVIVAL; DROPLET DIGITAL PCR; REGULATORY T-CELLS; PD-1; BLOCKADE; PERIPHERAL-BLOOD; INDUCE APOPTOSIS; OPEN-LABEL; NIVOLUMAB; PEMBROLIZUMAB;
D O I：
10.1097/PPO.0000000000000307
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer immunotherapy has recently undergone rapid advances and has become an integral part of the treatment armamentarium in various malignancies. However, tissue-based biomarker development in this arena has been slow, and valid biomarker identification to guide immunotherapeutic management is desperately needed. "Liquid" or blood-based biopsies potentially offer more convenient and efficient means to judge the immune milieu of individual patients and identify who will benefit most from immunotherapy. The following review highlights the current literature regarding the application of liquid biopsies to cancer immunotherapy.
引用
收藏
页码：78 / 83
页数：6
相关论文
共 50 条
  • [1] Implementing liquid biopsies into clinical decision making for cancer immunotherapy
    Quandt, Dagmar
    Zucht, Hans Dieter
    Amann, Arno
    Wulf-Goldenberg, Anne
    Borrebaeck, Carl
    Cannarile, Michael
    Lambrechts, Diether
    Oberacher, Herbert
    Garrett, James
    Nayak, Tapan
    Kazinski, Michael
    Massie, Charles
    Schwarzenbach, Heidi
    Maio, Michele
    Prins, Robert
    Wendik, Bjoern
    Hockett, Richard
    Enderle, Daniel
    Noerholm, Mikkel
    Hendriks, Hans
    Zwierzina, Heinz
    Seliger, Barbara
    ONCOTARGET, 2017, 8 (29) : 48507 - 48520
  • [2] Liquid biopsy for lung cancer immunotherapy
    Cai, Liang-Liang
    Wang, Jie
    ONCOLOGY LETTERS, 2019, 17 (06) : 4751 - 4760
  • [3] Biomarkers for immunotherapy in bladder cancer: a moving target
    Aggen, David H.
    Drake, Charles G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Immunotherapy for Colorectal Cancer* *
    Xu, Hao-Ran
    Zhao, Xiao-Yi
    Nie, He
    Wang, Hui
    Zhang, Qing-Lin
    Zhan, Qiang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (10) : 2570 - 2586
  • [5] Immunotherapy for colorectal cancer
    Radecka, Barbara
    Gelej, Marek
    Kotyla, Monika
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (03): : 133 - 139
  • [6] Correlation between patients' age and cancer immunotherapy efficacy
    Wu, Qiong
    Wang, Qiuhong
    Tang, Xin
    Xu, Ran
    Zhang, Luzhong
    Chen, Xinming
    Xue, Qun
    Wang, Ziheng
    Shi, Rongfeng
    Wang, Feiran
    Ju, Fei
    Zhang, Bo
    Zhou, You Lang
    ONCOIMMUNOLOGY, 2019, 8 (04):
  • [7] Immunotherapy for Gastroesophageal Cancer
    Goode, Emily F.
    Smyth, Elizabeth C.
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (10)
  • [8] Updates in Immunotherapy for Pancreatic Cancer
    Chick, Robert Connor
    Pawlik, Timothy M.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [9] The current status of the clinical utility of liquid biopsies in cancer
    Snow, Anson
    Chen, Denaly
    Lang, Julie E.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (11) : 1031 - 1041
  • [10] Liquid biopsy for guiding breast cancer immunotherapy
    Fina, Emanuela
    Vitale, Elsa
    De Summa, Simona
    Gadaleta-Caldarola, Gennaro
    Tommasi, Stefania
    Massafra, Raffaella
    Brunetti, Oronzo
    Rizzo, Alessandro
    IMMUNOTHERAPY, 2025, : 369 - 383
12345